A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...
A new study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid ...
Boston scientists say a routine blood draw might spot the earliest changes of Alzheimer’s long before the brain lights up on high-tech scans, potentially shifting how and when the disease is caught.
Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.
By Dennis Thompson HealthDay ReporterWEDNESDAY, April 15, 2026 (HealthDay News) — A blood test can predict Alzheimer’s disease progression in a person’s brain years before they show any symptoms of ...
A new study shows that a blood test measuring plasma phosphorylated tau 217 (pTau217) can identify Alzheimer’s disease risk years before brain scans detect changes. Researchers found elevated pTau217 ...